Carbon Herald just published Caravel Bio Advances Low-Cost Carbon Capture Technology.
Carbon Herald reports that US startup Caravel Bio has made gains in stabilizing the enzymes it uses for carbon capture, a step the company frames as central to lowering the cost of biologically assisted CO2 removal. Enzymatic approaches typically rely on carbonic anhydrase or similar biocatalysts to accelerate CO2 absorption into solvents, but degradation under industrial conditions has been a long-standing barrier. The outlet positions Caravel’s work as part of a wider push to bring biological capture methods closer to commercial deployment alongside conventional amine-based systems.
Our take (Heads-up): Enzyme durability is the right metric to watch for this class of technology, so the framing is sensible. That said, the underlying claim needs specifics that the summary does not include: how many cycles, under what temperature and solvent conditions, and against which benchmark. Independent validation and peer-reviewed data would matter more here than a company milestone.
-> Read the full piece at Carbon Herald
Captain Drawdown is flagging this. The reporting is Carbon Herald’s. Go read them directly, not a rewrite from us.
Source: Carbon Herald